This website is available in:
To change websites, find a country in the A - Z list then choose a language.
To change websites, click on the map pins to find a country then choose a language.
HomeLife SciencesBiopharmaceutical ServicesClinical Research ServicesBiosimilar Testing Services
Biosimilar development is unlike that of a novel biotherapeutic or generic drug, which is why you need accurate analysis at every stage. From determining the exact sequence, structure and quality attributes of the originator to comparative head-to-head biosimilarity testing of the biosimilar with the originator, our biosimilar testing services provide vital analytics.
Our integrated biosimilar development platform is based on a step-by-step approach to help you move seamlessly through the critical stages of development – from product characterization and biosafety testing, to full comparability studies and clinical trials, including bioanalytical and bioassay.
We can help you:
As a world leader in biosimilar testing, we offer the experience and expertise to handle all of your testing requirements – from one source. Our biosimilar services provide a dedicated point of contact and include regulatory advice and consultancy to aid you through the process.
We have invested in a global laboratory network, providing centers of excellence in biopharmaceutical services and worldwide clinical research facilities, including a clinical pharmacology unit and seven offices across US and Europe. As a result, we can perform the complete range of laboratory analysis and clinical trial studies, including comparative studies and clinical efficacy trials, to demonstrate the biosimilarity of your molecule.
To discuss how our biosimilar testing services can help you, contact us today.